title: No Need to Sugarcoat the Message: Is Cardiovascular Risk Reduction From SGLT2 Inhibition Related to Natriuresis?
authors.affiliation: University of Toronto, Ontario, Canada.
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Perkins
authors.affiliation: University of Toronto, Ontario, Canada.
authors.forename: Jacob A
authors.initials: JA
authors.lastname: Udell
authors.affiliation: University of Toronto, Ontario, Canada. Electronic address: david.cherney@uhn.ca.
authors.forename: David Z I
authors.initials: DZ
authors.lastname: Cherney
mesh_terms: D002318:Cardiovascular Diseases; D006801:Humans; D007004:Hypoglycemic Agents; D009318:Natriuresis / Q000187:drug effects*; D012307:Risk Factors; D051297:Sodium-Glucose Transporter 2
chemical_list: D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2